SWITZERLAND > US based Boston Scientific to acquire Symetis for $435Mn

BostonScientificBlue USA based Boston Scientific is set to acquire Switzerland based Symetis for $435 million. The all-cash deal is expected to close in second quarter of 2017 after customary closing conditions are met. Symetis specializes in the development, manufacturing and marketing of percutaneous heart valve replacement solutions for the treatment of severe cardiac valve conditions.   About Symetis Symetis is a medical More …